Clinical trial
Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the…
NCT00149136 · Hospices Civils de Lyon, Other · Unknown status
Key facts
| NCT number | NCT00149136 |
|---|---|
| Title | Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy. |
| Official title | Evaluation of Imatinib (GLIVEC) After Induction Therapy in Patients Aged More Than 55 Years With Philadelphia Positive Acute Lymphoblastic Leukaemia (Ph+ ALL) : a Non Randomised, Controlled, Open, Multicentric, International Phase II Clinical Study (CSTI 571 AFR09 Trial) |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | imatinib |
| Enrollment | 30 |
| Start date | Aug 1, 2002 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 27, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: